Noninvasive Encapsulated Follicular Variant of Papillary Thyroid Cancer: Clinical Lessons from a Community-Based Endocrine Surgical Practice

Table 1

Demographics, US, surgery and pathology results in 37 noninvasive EFVPTC patients.

Patient	Gender	Age	EFVPTC size (cm)	Echo type	Cytology	Afirma GEC	Operation	Nodes	Other cancer
	F	34	6.1	Iso	FN/SFN		TT	0/1	No
2	M	52	5.6	Hetero	Benign		LHT, RHT	0/1	No
3	F	31	4.7	Iso	Benign		TT		MicroPTC-c
4	F	69	6.9	Hypo	FN/SFN	Benign	TT	0/0	No
5	F	36	4.5	Hypo			TT	0/0	MicroPTC-c
	F	27	4.2	Hetero	FLUS/AUS		LHT	0/1	No
7	F	55	5.8	Iso			LHT	0/0	No
8	M	30	4.1	Iso	FLUS/AUS	Suspicious	RHT	0/0	No
9	F	51	3.9	Hetero	FLUS/AUS	Suspicious	TT	0/1	MicroFvPTC
10	M	56	3.6	Hetero	FLUS/AUS	Suspicious	LHT	0/3	MicroPTC
11	F	41	4.4	Iso	FN/SFN	Suspicious	RHT	0/0	No
12	F	50	3.1	Iso			LHT	0/2	No
13	F	38	3.8	Iso			LHT	0/1	No
14	F	30	2.8	Iso	FN/SFN		LHT	0/1	No
15	F	35	2.6	Hetero	Benign		TT	0/1	No
16	F	21	3.15	Hetero	FN/SFN		RHT	0/1	No
17	F	50	2.4	Hypo	Benign		TT	0/3	MicroPTC
18	F	60	3	Iso	FLUS/AUS	Suspicious	TT	0/0	MicroFvPTC
19	F	46	1.4	Hypo	FLUS/AUS	Suspicious	RHT	0/1	No
20	M	38	3	Iso	FLUS/AUS	Suspicious	TT	0/2	MicroPTC
21	F	32	3.3	Iso	FN/SFN	Suspicious	TT	0/0	No
22	M	53	2.5	Iso	FN/SFN		RHT	0/0	No
23	F	16	2.7	Iso	Benign		LHT, RHT	0/1	MicroFvPTC-c
24	F	37	2.63	Hypo	FLUS/AUS		TT	0/3	No
25	F	53	1.9	Hypo			LHT, RHT	0/1	2.1 cm FVPTC and microFVPTC-c
26	F	56	2.53	Hetero	Benign		RHT, LHT	0/1	MicroPTC
27	F	55	1.6	Hypo	FLUS/AUS		TT	0/1	No
28	M	39	2.1	Iso	FLUS/AUS	Suspicious	LHT	0/1	No
29	F	40	1.3	Hypo	FLUS/AUS	Suspicious	TT	0/0	No
30	M	64	1.6	Hypo	Benign		TT	0/0	No
31	F	58	1.3	Iso	FLUS/AUS	Suspicious	LHT	0/1	MicroPTCs
32	F	55	1.1	Iso	FLUS/AUS	Suspicious	TT	0/0	No
33	F	37	0.8	Iso			TT	0/4	No
	F	37	1.3	Iso			TT + CND		1.5 cm PTC-c
35	F	45	0.9	Iso	FLUS/AUS	Suspicious	TT	0/0	2 cm FvPTC
36	F	32	4	Iso	FN/SFN		TT	0/0	No
37	M	56	4.3	Iso	Benign		TT	0/0	No

Patient treated with radioiodine, PAX8/PPAR gamma translocation, NRAS mutation, nodal micrometastases, and -c contralateral lobe from encapsulated EFVPTC tumor.